Risperdal Whistleblower: J&J Credo Is ‘Empty Words’
43 CommentsBy Ed Silverman // January 25th, 2012 // 10:29 am
• Pharma Blog » Archives
Off Label Promotion
J&J Warned By FDA Over Remarks By Sales Rep
3 CommentsBy Ed Silverman // January 10th, 2012 // 8:33 am
J&J May Pay $1B To Make Risperdal Probe Go Away
5 CommentsBy Ed Silverman // January 5th, 2012 // 4:22 pm
FDA Issues Social Media Guidance… Well, Sort Of
Make a commentBy Ed Silverman // January 4th, 2012 // 7:56 am
Roche Pays $20M To Settle Whistleblower Lawsuit
4 CommentsBy Ed Silverman // December 2nd, 2011 // 10:38 am
Off-Label Marketing & Free Speech: Piety Explains
11 CommentsBy Ed Silverman // November 15th, 2011 // 9:46 am
Glaxo To Pay $3B To Settle Marketing Probes
13 CommentsBy Ed Silverman // November 3rd, 2011 // 7:06 am
Par Pharma: Free Speech Muffled By The FDA
23 CommentsBy Ed Silverman // October 17th, 2011 // 9:02 am
Feds Probe Cephalon For Off-Label Treanda Promotion
21 CommentsBy Ed Silverman // July 11th, 2011 // 9:51 am
The FDA And Its Pilot Pharma Fraud Program
5 CommentsBy Ed Silverman // January 26th, 2011 // 11:46 am